Brian Ung

Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

Sunnie S. Y. Kim, James Signorovitch, Hongbo Yang et al. · Advances in Therapy · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacology +8

Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma

Shaloo Gupta, Safiya Abouzaid, Ryan Liebert et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 37 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Performance-Based Risk-Sharing Arrangements: U.S. Payer Experience

Joseph A. Goble, Brian Ung, Sascha van Boemmel-Wegmann et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 20 citations · Full text

Health Professions, Health Administration, Health Services Administration +11

Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry

Sundar Jagannath, Robert M. Rifkin, Cristina Gasparetto et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 20 citations · Full text

Medicine, Oncology, Pharmacoeconomics +13

Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis

Jashin J. Wu, Corey Pelletier, Brian Ung et al. · Journal of Medical Economics · 2019 · 19 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13